Overview

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.
Phase:
Phase 4
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Ibuprofen